Back to library
Mitochondrial Peptide

MOTS-C

Mitochondrial-derived peptide studied for AMPK activation, metabolic signaling, insulin sensitivity, and exercise-capacity research.

Vial

10 mg vial

Category

Mitochondrial Peptide

Research highlights

A mitochondrial-derived peptide studied for AMPK-related metabolic signaling.
Research examines glucose uptake, fatty-acid oxidation, and mitochondrial respiration.
No completed human clinical trials are reflected in the source literature.

How this works

MOTS-C is researched as a mitochondrial stress signal that activates AMPK-related pathways, influencing glucose uptake, fatty-acid oxidation, mitochondrial respiration, and cellular stress-response signaling.

Storage

  • Lyophilized: store frozen, dry, and dark.
  • Reconstituted: refrigerate at 2–8 °C and use within 7 days for best potency.
  • Aliquoting may help avoid repeated freeze–thaw cycles.

Research-use notice

⚠️ All peptides on this site are not FDA approved and are not approved for human use outside of a clinical trial. f4Labs presents this material as a research reference only — not medical advice, diagnosis, or treatment guidance.

Peer-Reviewed References

Mechanism descriptions and research context are informed by the following published literature. Click any citation to view the source.

  1. 1
    Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. doi:10.1016/j.cmet.2015.02.009.View source
  2. 2
    Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021. doi:10.1038/s41467-021-26459-2.View source
  3. 3
    Kim SJ, et al. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017. doi:10.1113/JP272472.View source